Cargando…
Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments?
Nowadays, non-alcoholic fatty liver disease is one of the first causes of liver transplant worldwide; many efforts have been done to find the perfect drug for this multifactorial disease. Presently we just have a few drugs that could be used in specific and limited clinical scenarios. Current eviden...
Autores principales: | Juárez-Hernández, Eva, Velázquez-Alemán, Alain P., Castro-Narro, Graciela, Uribe, Misael, López-Méndez, Iván |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745034/ https://www.ncbi.nlm.nih.gov/pubmed/36523596 http://dx.doi.org/10.3389/fendo.2022.1026444 |
Ejemplares similares
-
Hunger & satiety signals: another key mechanism involved in the NAFLD pathway
por: López-Méndez, Iván, et al.
Publicado: (2023) -
Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients
por: Ordoñez-Vázquez, Ana Luisa, et al.
Publicado: (2022) -
Increased plasma genistein after bariatric surgery could promote remission of NAFLD in patients with obesity
por: Wang, Geng, et al.
Publicado: (2023) -
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: Lopez-Mendez, Ivan, et al.
Publicado: (2021) -
Endoscopic Management of Weight Recurrence Following Bariatric Surgery
por: Abboud, Donna Maria, et al.
Publicado: (2022)